The stem and roots of Wilms' tumours
نویسنده
چکیده
» . . . Pode-Shakked et al. now identify NCAMþALDH1þ cells as WT CSC . . . « 19th century the ‘embryonal rest’ theory proposed that cancers originate from cells that resemble those from an early embryo (for a highly recomendable review and historic overview of the CSC field; see Nguyen et al, 2012). The CSC model that eventually emerged from this has several attractive aspects for the description and treatment of cancer. By postulating that tumours harbour a small subset of cancer stem cells that give rise, through differentiation and proliferation, to the bulk of the tumour, as well as new CSC through self-renewal, the heterogeneity of tumours can be explained. Through parallels with the normal development of the corresponding normal cell types the CSC model can help describe the earliest steps in the tumourigenic process before a fully malignant tumour is formed. Finally it predicts that the CSC should be the preferred targets of therapy, but also that due to their stem cell (-like) state they are often less responsive to the usual therapies. Much early work on CSC has been done in haematopoietic malignancies, maybe not surprisingly as large parts of their developmental cascade happens and can be followed postnatally, followed by a spur in the identification of CSC from adult
منابع مشابه
Evaluation of CD133 and CD56/NCAM expression in Wilms tumor and their association with prognostic factors
Objective(s): To validate certain markers for cancer stem cell populations and their clinical importance in Wilms tumor (WT)Materials and Methods: Immunohistochemical study for CD133 and CD56/NCAM was performed on forty-six cases of WT that were diagnosed between 1999 and 2015, and the association of these markers with survival and progn...
متن کاملGermline mutations in the PAF1 complex gene CTR9 predispose to Wilms tumour
Wilms tumour is a childhood kidney cancer. Here we identify inactivating CTR9 mutations in 3 of 35 Wilms tumour families, through exome and Sanger sequencing. By contrast, no similar mutations are present in 1,000 population controls (P<0.0001). Each mutation segregates with Wilms tumour in the family and a second mutational event is present in available tumours. CTR9 is a key component of the ...
متن کاملImprinting, expression, and localisation of DLK1 in Wilms tumours.
BACKGROUND Loss of imprinting (LOI) of the H19/IGF2 domain is a common feature of Wilms tumour. The GTL2/DLK1 domain is also imprinted and is structurally similar to H19/IGF2. The question arises as to whether DLK1 also undergoes LOI in Wilms tumour, or whether the LOI mechanism is restricted to the H19/IGF2 domain. AIM To investigate the imprinting status of DLK1 in Wilms tumours with IGF2 L...
متن کاملDiagnostic utility of Wilms’ tumour-1 protein (WT-1) immunostaining in paediatric renal tumours
BACKGROUND & OBJECTIVES Renal tumours constitute about 7 per cent of all neoplasms in children. It is important to differentiate Wilms' tumour (commonest tumour) from non-Wilms' tumours. The aim of this study was to evaluate the immunoexpression and diagnostic role of Wilms' tumour-1 protein (WT1) in paediatric renal tumours. METHODS A total of 53 cases of renal tumours in children (below 18 ...
متن کاملClassification of a frameshift/extended and a stop mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferation
The WT1 gene encodes a zinc finger transcription factor important for normal kidney development. WT1 is a suppressor for Wilms tumour development and an oncogene for diverse malignant tumours. We recently established cell lines from primary Wilms tumours with different WT1 mutations. To investigate the function of mutant WT1 proteins, we performed WT1 knockdown experiments in cell lines with a ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 5 شماره
صفحات -
تاریخ انتشار 2013